The tweet was deleted by the author.
But we saved everything 🙂.
REGENXBIO has been recognized as a 2026 WTOP Top Workplace and has also won a Top Workplaces USA award from USA TODAY.
The company credited its team for fostering an environment where both people and scientific innovation thrive. Such accolades are considered significant markers of excellence in corporate culture and employee engagement among U.S. life sciences companies.
Earlier this year, REGENXBIO reported promising pivotal data for its RGX-202 Duchenne muscular dystrophy program at a national conference, according to company disclosures. The company also joined the global MPS community in Florence to support international collaboration on lysosomal disease research, as noted in previous coverage. Both efforts highlight REGENXBIO’s recent involvement in advancing treatments for rare diseases.